Biden administration

;

House proposes to gut ending HIV programs

Jul 19, 2023

“While we appreciate the sustained funding for many domestic HIV and hepatitis programs, we are devastated by the proposal to virtually eliminate the Ending the HIV Epidemic initiative,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We were on a trajectory to end HIV by ensuring all people have access to care and treatment, and prevent new infections through increasing access to PrEP, but now all those efforts will be lost. This bill cannot stand as is.”

read more

Nation must do better in ensuring patients receive hepatitis C curative drugs

Jun 29, 2023

“This situation is completely unacceptable. We have a cure for a serious infectious disease, but people who have taken the time to get tested and know they have hepatitis C are not being cured,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “The vast majority of these people have health coverage but payers such as private insurers, state Medicaid programs, and Medicare are erecting barriers to patient access by not covering medications or requiring cumbersome prior authorizations or imposing high patient cost-sharing. If the federal government is serious about ending hepatitis C, it needs to provide the leadership, particularly at CMS, and address these payer barriers.”

read more

New CDC HIV data demonstrates importance of federal funding

May 23, 2023

CDC data released today shows that overall, the nation is on the right trajectory in decreasing the number of new HIV diagnoses with a marked decrease in new cases among young people. At the same time, while usage of PrEP, which are drugs that prevent HIV, significantly increased, it mostly benefited Whites, while the wide disparities in uptake for Blacks, Latinos, and women persisted.

read more

Biden budget boosts domestic HIV funding & proposes PrEP & Hepatitis C programs

Mar 9, 2023

“President Biden’s budget is yet another demonstration of his leadership in ending HIV. He recognizes the historic role the federal government must play, and the investments needed to end infectious diseases, such as HIV and hepatitis C,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “Now, it is essential that Congress works together to ensure it maintains the federal government’s commitment to ending HIV and at the same time, invests the necessary resources to end hepatitis. We also must guard against any erosion in funding of these programs, as some have proposed,” continued Schmid.

read more

FDA proposes to lift discriminatory blood donation ban for gay men

Jan 27, 2023

HIV+Hep’s Carl Schmid issued the following statement: “This marks a monumental shift and ends a long and painful era of blanket discrimination against gay men. No longer will eligibility to donate blood be based on sexual orientation.  Instead, every person, no matter their sexuality, will be reviewed individually in order to determine their eligibility to donate.  While this long-overdue change is being made based on the science and the facts, which have been clear for years, it is the result of the leadership of the Biden administration that continues to tear down discriminatory government policies.”

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest